Ikonisys S.A. (EPA:ALIKO)

Market Cap	25.43M +26.0%
Revenue (ttm)	1.47M +81.2%
Net Income	-2.86M
EPS	-0.20
Shares Out	15.84M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	7,324
Average Volume	21,439
Open	1.620
Previous Close	1.620
Day's Range	1.605 - 1.650
52-Week Range	1.280 - 1.840
Beta	0.73
RSI	51.25
Earnings Date	Apr 30, 2026

About Ikonisys

Ikonisys S.A., a cell-based diagnostics company, develops, produces, and markets medical diagnostic products for early and accurate detection of cancer diseases in the United States and Europe. It offers Ikoniscope Robotic Microscopes, including Ikoniscope20 that provides automated slide handling, slide scanning, and real-time image capture and analysis; and Ikoniscope20max that automates the fluorescence microscopy solution. The company also provides oncoFISH bladder that allows scanning and analysis of cells from a voided urine sample; oncoFI...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2021
• Employees: 15
• Stock Exchange: Euronext Paris
• Ticker Symbol: ALIKO

Financial Performance

In 2024, Ikonisys's revenue was 1.01 million, an increase of 56.72% compared to the previous year's 645,173. Losses were -3.24 million, 42.9% more than in 2023.